In the west, children and adolescents, particularly females, identifying as ‘trans’ has increased exponentially over the past decade. In parallel, trans-activists have lobbied for puberty blockers and affirmative hormones to be available to minors. In some instances, without full exploration of associated comorbidities.  What are the health implications of treating gender dysphoria in young people?   In part 1, we sit down with three passionate experts Dr Helen Joyce - Author, Researcher & Executive Editor - The Economist, Dr Ada Chueng - Endocrinologist & transhealth expert and Dr Sav Swicki - Non-binary transgender researcher and LGBTIQA+ community worker.    See omnystudio.com/listener for privacy information.